Laboratoires Fournier Sa

Fournier Industrie Et Sante

Laboratories Fournier S.a.

Christine Dumas

Luc Lebreton

Christine Massardier

Pierre Dodey

Michel Bondoux

Patrice Renaut

Philippe Masson

Benzenesulfonamide derivative compounds corresponding to the general formula (I): and their pharmaceutically acceptable addition salts; a process for preparation of such compounds; pharmaceutical compositions containing such compounds, and the use of such compounds as a pharmacologically active substance, in particular in the treatment of neurodegenerative diseases, cardiovascular diseases, inflammatory diseases; hypercholesterolemia, and diabetes.

LXR receptor modulators

Sulfonylindoline compounds of formula I, wherein R1 through R4, Y and Z have defined meanings, a process for preparation of such compounds, and the use as pharmaceutically active substances, particularly for the treatment or inhibition of neurodegeneration, cardiovascular disease, inflammatory disease, hypercholesterolemia, dyslipidemia, obesity or diabetes.

Indoline compounds

The present invention relates to a novel compound selected from the group consisting of: (i) the compounds of the formula ##STR1## in which: A is a group --CO--NH-- or a group --NH--CO--,

15-deoxyspergualin analogs, their method of preparation and their use in

Growing community of inventors

Talant, France

Christine Dumas